Edaravone Market By End-users ( Clinics, Hospitals ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 148

 ERC 7196

Edaravone Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Edaravone is a neuroprotective agent that is mainly available in the global market under the trademark ‘Radicava’ and ‘Radicut’. Since its advent in the late 1980s, edaravone is gaining popularity among patients recovering from stroke and those who are suffering from amyotrophic lateral sclerosis (ALS). Edaravone set foot in the US market in 2017 after the approval of FDA for its use in the treatment of ALS. Similarly, the drug was approved in Japan in June 2015, followed by South Korea in December 2015 for its application in amyotrophic lateral sclerosis treatment.

The global edaravone market is expected to witness an impressive growth during the upcoming years due to the unavailability of an approved alternative drug for treating ALS, except riluzole. However, edaravone has proved to be effective in slowly deteriorating the ALS symptoms, which is not the case with riluzole. Riluzole is an effective drug that could only delay death from the disease for several months. As per the data revealed by the Centers for Disease Control and Prevention, each year approximately 12,000-15,000 people are affected with ALS in the United States alone. In addition, nearly 5,000-6,000 new people are diagnosed with amyotrophic lateral sclerosis in the US, every year. Such alarming figures are expected to fuel the growth of global edaravone market during the upcoming years. Moreover, the continuous research and development in the medicine industry is expected to offer lucrative opportunities to the market players in the upcoming years.

The report provides detailed qualitative and quantitative analysis of the global edaravone market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the end-user segment in each of the major regions of the world.

Global Edaravone Market Player Analysis -

The report presents detailed analysis of major players operating in global edaravone market. Few of them include Mitsubishi Tanabe Pharma, Unichem Laboratories Ltd, Simcere, Taj Pharmaceuticals Ltd., UCB India Ltd, Piramal Healthcare, and Sun Pharmaceutical Industries Ltd. Detailed coverage on these market players with information on their revenue from edaravone business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global edaravone market is segmented on the basis of end-user, and geography. By end-user, the market is segmented into clinics, hospitals, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Edaravone Market Segmentation

By End-users
   • Clinics
   • Hospitals
   • Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Edaravone Market Key Players

• Mitsubishi Tanabe Pharma
• Unichem Laboratories Ltd
• Simcere
• Taj Pharmaceuticals Ltd.
• UCB India Ltd
• Piramal Healthcare
• Sun Pharmaceutical Industries Ltd.

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Edaravone Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Edaravone Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?


Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com